Compare Stocks: TALK, WGS, AVAH, and NEO

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVAH Aveanna Healthcare	$12.79 -3.3%	$11.86	$5.93 ▼ $14.71	$2.88B	1.97	3.07 million shs	2.43 million shs
NEO NeoGenomics	$18.36 -2.8%	$16.65	$7.07 ▼ $20.05	$2.43B	1.75	1.94 million shs	2.91 million shs
TALK Talkspace	$5.25	$5.23	$2.49 ▼ $5.25	$879.43M	1.1	1.63 million shs	N/A
WGS GeneDx	$85.20 -6.2%	$79.35	$32.21 ▼ $170.87	$2.71B	1.99	574,745 shs	1.05 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVAH Aveanna Healthcare	-1.64%	-7.62%	+0.46%	+56.08%	+57.38%
NEO NeoGenomics	-2.68%	0.00%	+11.25%	+46.43%	+124.88%
TALK Talkspace	0.00%	0.00%	0.00%	+1.06%	+101.15%
WGS GeneDx	-7.19%	-4.06%	+4.28%	+42.90%	-30.04%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVAH Aveanna Healthcare	$12.79 -3.3%	$11.86	$5.93 ▼ $14.71	$2.88B	1.97	3.07 million shs	2.43 million shs
NEO NeoGenomics	$18.36 -2.8%	$16.65	$7.07 ▼ $20.05	$2.43B	1.75	1.94 million shs	2.91 million shs
TALK Talkspace	$5.25	$5.23	$2.49 ▼ $5.25	$879.43M	1.1	1.63 million shs	N/A
WGS GeneDx	$85.20 -6.2%	$79.35	$32.21 ▼ $170.87	$2.71B	1.99	574,745 shs	1.05 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVAH Aveanna Healthcare	-1.64%	-7.62%	+0.46%	+56.08%	+57.38%
NEO NeoGenomics	-2.68%	0.00%	+11.25%	+46.43%	+124.88%
TALK Talkspace	0.00%	0.00%	0.00%	+1.06%	+101.15%
WGS GeneDx	-7.19%	-4.06%	+4.28%	+42.90%	-30.04%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVAH Aveanna Healthcare	2.67	Moderate Buy	$14.06	9.68% Upside
NEO NeoGenomics	2.70	Moderate Buy	$17.67	-3.70% Downside
TALK Talkspace	2.00	Hold	$5.56	5.95% Upside
WGS GeneDx	2.89	Moderate Buy	$89.57	4.90% Upside

Current Analyst Ratings Breakdown

Latest TALK, WGS, AVAH, and NEO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/14/2026	AVAH Aveanna Healthcare	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$8.00 ➝ $15.00
8/28/2026	AVAH Aveanna Healthcare	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$9.50 ➝ $15.00
8/26/2026	WGS GeneDx	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/24/2026	AVAH Aveanna Healthcare	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$11.00 ➝ $15.00
8/24/2026	AVAH Aveanna Healthcare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$10.00 ➝ $16.00
8/14/2026	AVAH Aveanna Healthcare	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Strong-Buy	$13.00 ➝ $15.00
8/14/2026	AVAH Aveanna Healthcare	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$8.00 ➝ $13.00
8/14/2026	AVAH Aveanna Healthcare	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$10.00 ➝ $14.00
8/7/2026	TALK Talkspace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/4/2026	WGS GeneDx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D)
8/4/2026	WGS GeneDx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$75.00 ➝ $90.00

(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVAH Aveanna Healthcare	$2.43B	1.15	$0.66 per share	19.49	$0.93 per share	13.78
NEO NeoGenomics	$727.33M	3.24	$0.32 per share	57.93	$6.47 per share	2.84
TALK Talkspace	$228.87M	3.84	$0.06 per share	81.52	$0.71 per share	7.39
WGS GeneDx	$427.54M	5.96	$2.00 per share	42.68	$10.54 per share	8.10

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVAH Aveanna Healthcare	$225.03M	$1.23	10.42	14.73	0.82	10.56%	80.70%	7.42%	11/5/2026 (Estimated)
NEO NeoGenomics	-$108.03M	-$0.40	N/A	366.92	N/A	-6.77%	-1.99%	-1.21%	10/27/2026 (Estimated)
TALK Talkspace	$7.79M	N/A	N/A	23.86	N/A	0.08%	0.17%	0.14%	10/29/2026 (Estimated)
WGS GeneDx	-$21.02M	-$3.64	N/A	74.25	N/A	-23.41%	4.12%	2.26%	10/27/2026 (Estimated)

Latest TALK, WGS, AVAH, and NEO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	AVAH Aveanna Healthcare	$0.1683	$0.22	+$0.0517	$0.18	$638.61 million	$670.48 million
8/6/2026	Q2 2026	TALK Talkspace	$0.0123	-$0.01	-$0.0223	-$0.01	$67.99 million	$61.67 million
8/3/2026	Q2 2026	WGS GeneDx	-$0.1879	$0.01	+$0.1979	-$0.60	$111.01 million	$114.44 million
7/28/2026	Q2 2026	NEO NeoGenomics	$0.0336	$0.05	+$0.0165	$0.02	$196.93 million	$201.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVAH Aveanna Healthcare	N/A	N/A	N/A	N/A	N/A
NEO NeoGenomics	N/A	N/A	N/A	N/A	N/A
TALK Talkspace	N/A	N/A	N/A	N/A	N/A
WGS GeneDx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVAH Aveanna Healthcare	4.47	1.16	1.16
NEO NeoGenomics	0.48	3.60	3.35
TALK Talkspace	N/A	4.52	4.52
WGS GeneDx	0.40	3.30	3.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVAH Aveanna Healthcare	87.96%
NEO NeoGenomics	98.50%
TALK Talkspace	57.37%
WGS GeneDx	61.72%

Insider Ownership

Company	Insider Ownership
AVAH Aveanna Healthcare	5.30%
NEO NeoGenomics	1.10%
TALK Talkspace	23.50%
WGS GeneDx	25.17%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVAH Aveanna Healthcare	35,500	218.22 million	206.65 million	Optionable
NEO NeoGenomics	2,500	128.48 million	127.06 million	Optionable
TALK Talkspace	500	167.51 million	128.15 million	Optionable
WGS GeneDx	1,300	29.82 million	22.32 million	Optionable

TALK, WGS, AVAH, and NEO Headlines

Recent News About These Companies

GeneDx (NASDAQ:WGS) Stock Price Down 6.5% - Here's Why

September 22 at 11:19 AM | marketbeat.com

Corient Private Wealth LP Makes New $3.07 Million Investment in GeneDx Holdings Corp. $WGS

September 21 at 3:12 AM | marketbeat.com

GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock

September 19, 2026 | insidertrades.com

Insider Selling: GeneDx (NASDAQ:WGS) CFO Sells $363,890.08 in Stock

September 18, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) CEO Sells $1,025,002.61 in Stock

September 18, 2026 | marketbeat.com

Financial Contrast: GeneDx (NASDAQ:WGS) versus Hinge Health (NYSE:HNGE)

September 18, 2026 | americanbankingnews.com

GeneDx Holdings Corp. (NASDAQ:WGS) Given Average Recommendation of "Moderate Buy" by Brokerages

September 16, 2026 | americanbankingnews.com

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Rating of "Moderate Buy" from Analysts

September 16, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Trading Up 4.2% - What's Next?

September 15, 2026 | marketbeat.com

How Genedx Holdings Corp. (WGS) Affects Rotational Strategy Timing

September 14, 2026 | news.stocktradersdaily.comN

Insider Selling: GeneDx (NASDAQ:WGS) CEO Sells $310,940.24 in Stock

September 14, 2026 | americanbankingnews.com

GeneDx (NASDAQ:WGS) CFO Kevin Feeley Sells 1,285 Shares of Stock

September 12, 2026 | insidertrades.com

Kevin Feeley Sells 1,285 Shares of GeneDx (NASDAQ:WGS) Stock

September 11, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 3,692 Shares of Stock

September 11, 2026 | marketbeat.com

First Light Asset Management LLC Has $53.82 Million Position in GeneDx Holdings Corp. $WGS

September 10, 2026 | marketbeat.com

3 Promising Genomics Stocks in the Spotlight in 2026

September 8, 2026 | zacks.com

Bank of New York Mellon Corp Invests $4.26 Million in GeneDx Holdings Corp. $WGS

September 6, 2026 | marketbeat.com

GeneDx (NASDAQ:WGS) Upgraded to "Strong-Buy" at Zacks Research

August 28, 2026 | marketbeat.com

GeneDx Holdings Corp (WGS) Shares Surge 3.3% -- What GF Score of 65 Tells Investors

August 26, 2026 | gurufocus.com

Royal Bank of Canada Has $571,000 Stock Holdings in GeneDx Holdings Corp. $WGS

August 25, 2026 | marketbeat.com

GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s

August 24, 2026 | uk.finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

TALK, WGS, AVAH, and NEO Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

$12.79 -0.43 (-3.25%)

Closing price 04:00 PM Eastern

Extended Trading

$12.80 +0.01 (+0.04%)

As of 07:33 PM Eastern

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

NeoGenomics NASDAQ:NEO

$18.36 -0.53 (-2.81%)

Closing price 04:00 PM Eastern

Extended Trading

$18.20 -0.16 (-0.87%)

As of 07:57 PM Eastern

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

Talkspace NASDAQ:TALK

Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.

GeneDx NASDAQ:WGS

$85.20 -5.60 (-6.17%)

Closing price 04:00 PM Eastern

Extended Trading

$85.34 +0.14 (+0.17%)

As of 07:52 PM Eastern

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TALK, WGS, AVAH, and NEO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TALK, WGS, AVAH, and NEO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TALK, WGS, AVAH, and NEO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TALK, WGS, AVAH, and NEO Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

NeoGenomics NASDAQ:NEO

Talkspace NASDAQ:TALK

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TALK, WGS, AVAH, and NEO Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TALK, WGS, AVAH, and NEO Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TALK, WGS, AVAH, and NEO Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

TALK, WGS, AVAH, and NEO Company Descriptions

Aveanna Healthcare NASDAQ:AVAH

NeoGenomics NASDAQ:NEO

Talkspace NASDAQ:TALK

GeneDx NASDAQ:WGS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools